Faculdade de Medicina de Valenca Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2006
NCT00591994
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Faculdade de Medicina de Valença

Active Ingredients

Drugs in Other Trials (2)

caffeine (1 trial)

Piribedil (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2